Skip to Content
Merck
CN

EHU072311

MISSION® esiRNA

targeting human RTN1

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.51
UNSPSC Code:
41105324
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


description

Powered by Eupheria Biotech

Quality Level

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

TAAGCACCAGGCACAGATTGACCAATATCTGGGACTTGTGAGGACTCACATAAATGCTGTTGTGGCAAAGATTCAGGCTAAAATCCCAGGCGCTAAGAGGCATGCTGAGTAAACTGATTTCCCACCGGGGACTGGACACAAACAGGAATGTCTGGAGTGGTAACAGCTCTCTTCTTACTCATTACTGCAAATTGATTGTCTTTCCCCCCTCCCTCCAGTACCATAATCTTAGAGACAAACCTTAAAACAGCTGTTTTTAGGCTGTTCCTTGTACTCTTAGGATATTTGAGTCACTTGTGTCAACCACTAAAGTATAGAGAAAAGTGTATTAGATGTGGTTTTTAATTTTGTGTTGCTAAAAAAAGTGCATGATGGTGAGAGCCCAAGTTATCTTTCCCTCTTCGGTGTTC

Ensembl | human accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... RTN1(6252)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany


Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Susanne Kramer-Hämmerle et al.
BMC cell biology, 6(1), 20-20 (2005-04-26)
Human cell types respond differently to infection by human immunodeficiency virus (HIV). Defining specific interactions between host cells and viral proteins is essential in understanding how viruses exploit cellular functions and the innate strategies underlying cellular control of HIV replication.
Ying Fan et al.
Nature communications, 6, 7841-7841 (2015-08-01)
Identification of new biomarkers and drug targets for chronic kidney disease (CKD) is required for the development of more effective therapy. Here we report an association between expression of reticulon 1 (RTN1) and severity of CKD. An isoform-specific increase in



Global Trade Item Number

SKUGTIN
EHU072311-50UG04061828372195
EHU072311-20UG04061828611713